- Home
- JAZZ vs ELAN Comparison
JAZZ vs ELAN Comparison
Compare JAZZ & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- ELAN
- Stock Information
- Founded
- JAZZ 2003
- ELAN 1954
- Country
- JAZZ Ireland
- ELAN United States
- Employees
- JAZZ N/A
- ELAN N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- JAZZ Health Care
- ELAN Health Care
- Exchange
- JAZZ Nasdaq
- ELAN Nasdaq
- Market Cap
- JAZZ 6.5B
- ELAN 6.3B
- IPO Year
- JAZZ 2007
- ELAN 2018
- Fundamental
- Price
- JAZZ $122.38
- ELAN $13.80
- Analyst Decision
- JAZZ Buy
- ELAN Buy
- Analyst Count
- JAZZ 14
- ELAN 6
- Target Price
- JAZZ $173.57
- ELAN $17.00
- AVG Volume (30 Days)
- JAZZ 613.8K
- ELAN 4.7M
- Earning Date
- JAZZ 11-06-2024
- ELAN 11-07-2024
- Dividend Yield
- JAZZ N/A
- ELAN N/A
- EPS Growth
- JAZZ 458.10
- ELAN N/A
- EPS
- JAZZ 7.04
- ELAN 0.41
- Revenue
- JAZZ $3,992,712,000.00
- ELAN $4,454,000,000.00
- Revenue This Year
- JAZZ $7.43
- ELAN $2.22
- Revenue Next Year
- JAZZ $6.39
- ELAN $2.77
- P/E Ratio
- JAZZ $17.64
- ELAN $34.22
- Revenue Growth
- JAZZ 5.23
- ELAN 1.99
- 52 Week Low
- JAZZ $99.06
- ELAN $11.20
- 52 Week High
- JAZZ $134.17
- ELAN $18.80
- Technical
- Relative Strength Index (RSI)
- JAZZ 59.35
- ELAN 53.55
- Support Level
- JAZZ $108.74
- ELAN $12.35
- Resistance Level
- JAZZ $128.99
- ELAN $14.71
- Average True Range (ATR)
- JAZZ 2.93
- ELAN 0.47
- MACD
- JAZZ 1.13
- ELAN 0.18
- Stochastic Oscillator
- JAZZ 62.86
- ELAN 60.21
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.